Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1989 Mar;63(3):1354–1359. doi: 10.1128/jvi.63.3.1354-1359.1989

Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus.

E Feduchi 1, M A Alonso 1, L Carrasco 1
PMCID: PMC247833  PMID: 2536838

Abstract

The replication of herpes simplex virus type 1 (HSV-1) is not inhibited in either HeLa or HEp-2 cells treated with human alpha interferon (HuIFN-alpha), particularly when high multiplicities of infection are used. However, HuIFN-gamma partially inhibits HSV-1 translation in HEp-2 cells infected at low multiplicities. Under these conditions, the transcription of genes alpha 22, TK, and gamma 0 is greatly diminished. The combined addition of human tumor necrosis factor (TNF) and HuIFN-gamma to HEp-2 cells exerts a synergistic inhibition of HSV-1 translation. Cells treated with both cytokines continue synthesizing cellular proteins, even 20 h after HSV-1 infection. As little as 10 U of IFN-gamma per ml blocked HSV-1 DNA replication, provided that TNF was also present in the medium. Analyses of HSV-1 gene transcription suggest that the action of both TNF and IFN-gamma blocked a step that comes at or prior to early HSV-1 gene expression. This early step in HSV-1 replication inhibited by TNF and IFN-gamma occurs after virus attachment and entry into cells, since the internalization of radioactive HSV-1 virion particles was not blocked by the presence of the two cytokines. Therefore, we conclude that the synergistic action of TNF plus IFN-gamma affects a step in HSV-1 replication that comes after virus entry but before or at the transcription of immediate-early genes.

Full text

PDF
1354

Images in this article

1356Image
on p.1356
1356Image
on p.1356
1357Image
on p.1357
1357Image
on p.1357
1357Image
on p.1357
1358Image
on p.1358

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler B., Greenwald D., Hulmes J. D., Chang M., Pan Y. C., Mathison J., Ulevitch R., Cerami A. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985 Aug 8;316(6028):552–554. doi: 10.1038/316552a0. [DOI] [PubMed] [Google Scholar]
  2. Blin N., Stafford D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 1976 Sep;3(9):2303–2308. doi: 10.1093/nar/3.9.2303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cayley P. J., Davies J. A., McCullagh K. G., Kerr I. M. Activation of the ppp(A2'p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2'p)nA-dependent RNase. Eur J Biochem. 1984 Aug 15;143(1):165–174. doi: 10.1111/j.1432-1033.1984.tb08355.x. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee S., Hunter E., Whitley R. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol. 1985 Nov;56(2):419–425. doi: 10.1128/jvi.56.2.419-425.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Domke-Opitz I., Straub P., Kirchner H. Effect of interferon on replication of herpes simplex virus types 1 and 2 in human macrophages. J Virol. 1986 Oct;60(1):37–42. doi: 10.1128/jvi.60.1.37-42.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Domke I., Straub P., Jacobsen H., Kirchner H., Panet A. Inhibition of replication of herpes simplex virus in mouse macrophages by interferons. J Gen Virol. 1985 Oct;66(Pt 10):2231–2236. doi: 10.1099/0022-1317-66-10-2231. [DOI] [PubMed] [Google Scholar]
  7. Favaloro J., Treisman R., Kamen R. Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping. Methods Enzymol. 1980;65(1):718–749. doi: 10.1016/s0076-6879(80)65070-8. [DOI] [PubMed] [Google Scholar]
  8. Feduchi E., Carrasco L. Adenovirus infection reverses the antiviral state induced by human interferon. FEBS Lett. 1987 Apr 6;214(1):153–157. doi: 10.1016/0014-5793(87)80032-7. [DOI] [PubMed] [Google Scholar]
  9. Feduchi E., Esteban M., Carrasco L. Reovirus type 3 synthesizes proteins in interferon-treated HeLa cells without reversing the antiviral state. Virology. 1988 Jun;164(2):420–426. doi: 10.1016/0042-6822(88)90555-7. [DOI] [PubMed] [Google Scholar]
  10. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  11. Lebleu B., Content J. Mechanisms of interferon action: biochemical and genetic approaches. Interferon. 1982;4:47–94. [PubMed] [Google Scholar]
  12. Mestan J., Digel W., Mittnacht S., Hillen H., Blohm D., Möller A., Jacobsen H., Kirchner H. Antiviral effects of recombinant tumour necrosis factor in vitro. 1986 Oct 30-Nov 5Nature. 323(6091):816–819. doi: 10.1038/323816a0. [DOI] [PubMed] [Google Scholar]
  13. Mistchenko A. S., Falcoff R. Recombinant human interferon-gamma inhibits adenovirus multiplication in vitro. J Gen Virol. 1987 Mar;68(Pt 3):941–944. doi: 10.1099/0022-1317-68-3-941. [DOI] [PubMed] [Google Scholar]
  14. Mittnacht S., Straub P., Kirchner H., Jacobsen H. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription. Virology. 1988 May;164(1):201–210. doi: 10.1016/0042-6822(88)90637-x. [DOI] [PubMed] [Google Scholar]
  15. Moran D. M., Kern E. R., Overall J. C., Jr Synergism between recombinant human interferon and nucleoside antiviral agents against herpes simplex virus: examination with an automated microtiter plate assay. J Infect Dis. 1985 Jun;151(6):1116–1122. doi: 10.1093/infdis/151.6.1116. [DOI] [PubMed] [Google Scholar]
  16. Muñoz A., Carrasco L. Action of human lymphoblastoid interferon on HeLa cells infected with RNA-containing animal viruses. J Gen Virol. 1984 Feb;65(Pt 2):377–390. doi: 10.1099/0022-1317-65-2-377. [DOI] [PubMed] [Google Scholar]
  17. Muñoz A., Carrasco L. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon. J Gen Virol. 1984 Jun;65(Pt 6):1069–1078. doi: 10.1099/0022-1317-65-6-1069. [DOI] [PubMed] [Google Scholar]
  18. Oberman F., Panet A. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells. J Gen Virol. 1988 Jun;69(Pt 6):1167–1177. doi: 10.1099/0022-1317-69-6-1167. [DOI] [PubMed] [Google Scholar]
  19. Old L. J. Tumor necrosis factor (TNF). Science. 1985 Nov 8;230(4726):630–632. doi: 10.1126/science.2413547. [DOI] [PubMed] [Google Scholar]
  20. Paez E., Esteban M. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology. 1984 Apr 15;134(1):12–28. doi: 10.1016/0042-6822(84)90268-x. [DOI] [PubMed] [Google Scholar]
  21. Shalaby M. R., Aggarwal B. B., Rinderknecht E., Svedersky L. P., Finkle B. S., Palladino M. A., Jr Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol. 1985 Sep;135(3):2069–2073. [PubMed] [Google Scholar]
  22. Stanwick T. L., Schinazi R. F., Campbell D. E., Nahmias A. J. Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1981 Apr;19(4):672–674. doi: 10.1128/aac.19.4.672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Straub P., Domke I., Kirchner H., Jacobsen H., Panet A. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages. Virology. 1986 Apr 30;150(2):411–418. doi: 10.1016/0042-6822(86)90306-5. [DOI] [PubMed] [Google Scholar]
  24. Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr, Shepard H. M. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science. 1985 Nov 22;230(4728):943–945. doi: 10.1126/science.3933111. [DOI] [PubMed] [Google Scholar]
  25. Thomas P. S. Hybridization of denatured RNA transferred or dotted nitrocellulose paper. Methods Enzymol. 1983;100:255–266. doi: 10.1016/0076-6879(83)00060-9. [DOI] [PubMed] [Google Scholar]
  26. Vilcek J., Palombella V. J., Henriksen-DeStefano D., Swenson C., Feinman R., Hirai M., Tsujimoto M. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med. 1986 Mar 1;163(3):632–643. doi: 10.1084/jem.163.3.632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wong G. H., Goeddel D. V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. 1986 Oct 30-Nov 5Nature. 323(6091):819–822. doi: 10.1038/323819a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES